Skip to main content

Table 1 Subject characteristics

From: Dietary changes in migrant adolescents with increasing length of stay in Australia and associated risk of wheeze – a retrospective, cross sectional study

N 144
Agea 13.6 (12.8–15.2)
Sex (%Males) 53.5
BMI (kg/m2) 20.2 (18.1–22.8)
FEV1, L 2.85 (2.40–3.40)
FVC, L (n = 116) 3.18 (2.79–3.80)
FEV1/FVC (n = 116) 0.90 (0.85–0.95)
DRS (%fall/mL) 0.22 (0.07–0.44)
Asthma Symptoms (%Yes) 28.5
Atopy (%Yes) 51.4
Wheeze (%Yes) 24.3
Asthma medication usage (%Yes)b 12.5
Years in Australia 3.0 (0.7–12.3)
Language (%English only) 34.7
  1. BMI Body mass index, FEV1 forced expiratory volume in 1 s; FVC forced vital capacity; DRS dose response slope
  2. aAll data are presented as Median (IQR) unless otherwise stated. bAsthma medications include: Alupent, Asmol, Atrovent, Becloforte, Becotide, Bricanyl, Flixotide, Pulmicorte, Respolin, Serevent, Theophylline, Ventolin